TrialMetabolic brain disease2026

Randomized, placebo-controlled trial of N-acetylcysteine in Parkinson's disease patients: a pilot study.

Bahar Moasses Ghafari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.